Curix
PrivateLast Round
Grant
Feb 10, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Curix operates in Healthcare & Life Sciences and is based in Enschede. Its latest recorded funding round was an Early Funding round in November 2023.
Curix is a medical technology company developing a drug delivery platform that uses a microbubble injector system and focused ultrasound to temporarily open the blood-brain barrier for treating neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Compliance & Risk, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curix Comparables
Compare Curix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inizio | 73% | |
| Ergomed plc | 70% | |
| Cencora | 70% |
For institutional investors. Book with your work email.
Curix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 10, 2026 | ||||
| Early Funding | Nov 21, 2023 |
For institutional investors. Book with your work email.
Curix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovative Health Initiative | Grant |
| Stichting Twinning Participaties | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
Received funding from the Innovative Health Initiative.
- Nov 21, 2023
Led by Stichting Twinning Participaties, an Impact Investor.
For institutional investors. Book with your work email.
Curix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curix's valuation, stock price, and market status.
Is Curix a public or private company?
Curix is a private company.
What is the current stock price of Curix?
Curix is a private company, so its shares have no public market price. Caplight tracks Curix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curix worth (valuation)?
Valuation information for Curix is not publicly available.
Can I buy Curix stock?
Curix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curix's last funding round?
Curix's most recent funding round was Grant on February 10, 2026.
Who are the main investors in Curix?
Key investors in Curix include Stichting Twinning Participaties.
Will Curix IPO soon?
No public IPO plans have been announced for Curix.
How can I track Curix secondary market activity?
Caplight tracks bids, offers, and trades in Curix's shares on secondary markets.